Role of interferon-stimulated gene factor 3 in inhibition of hepatitis B virus replication in vitro by interferon-α

ZHANG Quan,WEI Lai,RAO Hui-ying,JIANG Dong,WANG Jiang-hua,ZHU L,FEI Ran,CHENG Ming-liang

DOI: https://doi.org/10.3969/j.issn.1673-713X.2006.01.010

2006-01-01

Abstract:Objective To investigate the role of interferon-stimulated gene factor 3 (ISGF3) in the inhibition of hepatitis B virus (HBV) replication by interferon-α (IFN-α) in vitro. Methods HepG2 and HepG2.2.15 cells were used in this study. The cells were divided into control, IFN-α, genistein, and IFN-α+genistein groups. The quantity of HBV DNA in the supernatant of HepG2.2.15 cells and the intracellular HBV replication were detected by PCR and Southern blotting, respectively. The expression levels of signal transducer and activator of transcription 1 (STAT1), phosphorylated STAT2, ISGF3γ, and double-stranded RNA-dependent protein kinase (PKR) was evaluated using Western blotting to determine the role of ISGF3 in IFN-α-mediated inhibition of HBV replication in the HepG2 and HepG2.2.15 cells. Results In IFN-α group, the quantity of HBV DNA replicative intermediates decreased in the HepG2.2.15 supernatant, the expression levels of STAT1, phosphorylated STAT2, ISGF3γ, and PKR were up-regulated in both HepG2 and HepG2.2.15 cells. In the cells pretreated with genistein, the quantity of HBV DNA remained unchanged, and the expression levels of STAT1, phosphorylated STAT2, ISGF3γ, and PKR were down-regulated. Conclusions The JAK/STAT pathway plays a role in inhibiting of HBV replication by IFN-α, in which ISGF3 is a key factor.